TF
PRCT icon

Trek Financial’s Procept Biorobotics PRCT Stock Holding History

Trek Financial’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38,264
Closed -$3.07M – 456
2024
Q3 		$3.07M Sell
38,264
-3,460
-8% -$246K 0.23% 111
2024
Q2 		$2.55M Buy
+41,724
New +$2.48M 0.2% 118

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Trek Financial's PRCT Position: Q4 2024 in Review

Trek Financial sold out of Procept Biorobotics (PRCT) in Q4 2024, closing a stake of 38,264 shares — an estimated $3.07M sold.

Trek Financial first reported a position in PRCT in Q2 2024 and held it in 2 quarters. The position peaked at $3.07M in Q3 2024. 281 funds tracked by Wall St. Rank hold PRCT as of Q4 2024.

  • Trek Financial reported no remaining Procept Biorobotics position as of Q4 2024 after selling out during the quarter.
  • Trek Financial sold 38,264 Procept Biorobotics shares in Q4 2024, an estimated $3.07M.
  • Trek Financial first reported a position in Procept Biorobotics in Q2 2024 and held it in 2 quarters.
  • Trek Financial's Procept Biorobotics position peaked at $3.07M in Q3 2024.
  • 281 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2024.

Based on Trek Financial's 13F filing for Q4 2024, filed 13 Feb 2025.